Several tumor suppressor genes were shown to be inactivated by a process involving aberrant de novo methylation of their GC-rich promoters which is usually associated with transcriptional repression. The mechanisms underlying this process are poorly understood. In particular this abnormal methylation may be caused and/ or maintained by either de®ciency of some trans-acting factor(s) or by various malfunctions acting in cis. Here we studied the nature of aberrant methylation of the von Hippel-Lindau (VHL) disease tumor suppressor gene in a human clear cell renal carcinoma cell line, UOK 121, that contains a silent hypermethylated endogenous VHL allele. First, we transfected unmethylated VHL transgenes, driven by the VHL promoter, into UOK 121 cells. Next, to exclude possible position eects that may in¯uence methylation of the introduced VHL genes, we transferred a single chromosome 3, carrying an apparently normal hypomethylated VHL allele into the UOK 121 cells. Finally, we created somatic cell hybrids between UOK 121 and UMRC 6 cells containing a mutant VHL-expressing hypomethylated allele. In these three experiments both the methylation of the VHL promoter and the transcriptional status of the introduced and endogenous VHL alleles remained unchanged. Our results demonstrate that the putative trans-acting factors present in the UOK 121 and UMRC 6 cells are unable to induce changes in methylation pattern of the VHL alleles in all cell lines and hybrids studied. Taken together, the results indicate that cis-speci®c local features are pivotal in maintaining and perpetuating aberrant methylation of the VHL CpG island. Contribution of some putative trans-acting factors cannot be excluded during a period when the aberrant VHL methylation pattern was ®rst generated.
Introduction
Changes in DNA methylation patterns are guiding fundamental events in development and play essential roles in the functioning of normal dierentiated cells. Aberrant de novo methylation and silencing of cancer causing tumor suppressor genes may be an initiating event in carcinogenesis. The molecular mechanisms which control gene speci®c local de novo and maintenance methylation are still poorly understood (reviewed in Baylin et al., 1998) .
One of the models which has emerged from these studies holds that gene-speci®c methylation changes are governed by the interaction of trans-acting factors with sequence speci®c cis elements located within the gene locus. This model predicts that either mutations of the cis elements, or changes in trans-acting factors (which could be caused by trans mutations), or both may result in abnormal methylation of a particular gene. Con®rming this prediction, de®ciencies of certain trans factor(s) were found important for maintenance of aberrant methylation of the E-cadherin gene in epithelial carcinomas (Hennig et al., 1995; Gra et al., 1995) and the estrogen receptor gene in fibrosarcoma cells (Kuerbitz and Baylin, 1996) .
Also, cis-mutations in the imprinting center leading to aberrant heritable imprinting and methylation in the familial cases of Prader-Willi and Angelman syndromes have been discovered (Reis et al., 1994; Sutclie et al., 1994; Buiting et al., 1995 ).
An alternative model predicts that some, not yet understood,`epigenetic',`spontaneous' events which are not caused by any mutations in cis or in trans may be also implicated. Such events could probably induce abnormal methylation following treatment with somè nongenotoxic' carcinogens (Costa, 1995) . For instance, in mouse cells reversible heterochromatinization can be promoted by some nickel compounds which can interact directly with histone H1 and induce local de novo methylation which is stable (Lee et al., 1995) . Interestingly,`epimutations' are now considered a possible factor, which may cause imprinting defects in some sporadic Prader-Willi and Angelman syndrome cases (BuÈ rger et al., 1997; Buiting et al., 1998) .
In general these examples illustrate that very dierent types of events and malfunctions may contribute to formation and preservation of aberrant methylation patterns.
In the present work we studied mechanisms which maintain aberrant methylation of the VHL promoter. The VHL gene is expressed ubiquitously in normal tissues, however, in a subset of sporadic clear RCC (clear cell renal carcinomas), where the normal VHL DNA sequence is retained, the GC rich promoter and ®rst exon of the gene often become methylated and transcriptionally silenced. This abnormal hypermethylation occurs in 20% of sporadic clear RCC (Herman et al., 1994) . If hypermethylation in these cells is maintained due to some changes in VHL-speci®c cis methylation-protecting structures, one can predict that a normal VHL allele introduced into these cells would remain methylation-free. Conversely, when introduced into cells de®cient for trans-acting protecting factors, this VHL allele would become methylated. Therefore, it is expected, that hypo-and hypermethylated VHL alleles would not coexist in RCC cells permanently de®cient for trans-acting factors. On the other hand, cells carrying VHL alleles with mutant or otherwise faulty cis methylation-protecting structures would retain transferred VHL alleles in their original state of hypo-or hypermethylation. Therefore, the outcome of chromosome transfer or transfection of unmethylated VHL alleles into RCC cells which contain a methylated VHL allele would depend on which elements of the methylation-protecting mechanism are broken. The cis/trans model predicts that methylation will remain unchanged when it is caused by a faulty cis element. Any change in methylation could occur only in cells that were de®cient prior to fusion for the transacting factors.
To study the mechanism of VHL methylation in UOK 121 RCC cells carrying a methylated VHL endogene, we ®rst analysed the methylation status of VHL transgene promoters transfected into these cells. Secondly, a single chromosome 3, containing an active wild type VHL allele, was transferred into these cells. And ®nally, we created somatic cell hybrids using parental RCC cell lines containing methylated or normal VHL alleles. In each experimental setting the methylation pattern and transcriptional status of both transferred and endogenous VHL alleles were analysed before and after transfer.
Results

Transfected VHL promoter constructs are active in UOK 121 RCC cells
The VHL minigene construct, pRCpVHLm, containing sequences from 7647 to +710 (including the VHL GC-rich promoter), is transcriptionally active in the UMRC 6 clear cell type RCC cell line. These cells also express mRNA from an endogenous VHL allele in which a 10 bp stretch of exon 3 coding sequence is deleted. Transcriptional activity of both endogenous and transgenic VHL alleles in these cells was shown to be similar (Kuzmin et al., 1995) . In the present study we tested VHL-speci®c transcriptional capabilities of the UOK 121 cells, which lack endogenous VHL expression due to hypermethylation of the promoter and ®rst exon. We and others (Herman et al., 1994) have also shown that the promoter and reading frame of the VHL gene in these cells are free of mutations. The VHL expressing construct pRcpVHLm, containing a full-length VHL promoter was transfected into UOK 121 cells. G418-resistant clones were subjected to Southern analysis using a double digest with EcoRI and NotI (Figure 1 ). The pRCpVHLm plasmid contains two EcoRI sites bordering the transgene and a NotI site located in the middle of the VHL CpG island. In all transfectants, NotI was able to cut the VHL transgene indicating that the transgene's CpG island remained free of methylation. To further explore the methylation status of the transgenes, we used the bisul®te sequencing procedure for methylation analysis of the 27 CpG dinucleotides present in positions 7613 through 7121, within an Alu repeat, of the transfected VHL minigene (clone L24). All CpGs in the transgene were found free of methylation in contrast to the endogenous copy of the VHL gene in the UOK 121 cells where this region was heavily methylated. Transcriptional activity of the VHL transgene was also tested and found comparable to endogenous VHL expression in the parental non-transfected UMRC 6 cells (see Figure 5 ). These observations indicate that the UOK121 carcinoma cells possess apparently all necessary VHL-speci®c transcription factors. The methylation free status of the VHL transgenes in the UOK 121 cells further suggests that the trans-acting factors are present in these cells, and are able to protect the transgene's CpG islands from de novo methylation. Alternatively, these particular VHL transgenes might not possess the entire cis elements proposed to be involved in de novo methylation. To test this possibility, the UOK 121 cells were transfected with cosmid 11 (Figure 2 ), which contains 38 kb of genomic DNA, including 5 kb of the VHL locus (GenBank accession #AF010238) (promoter, exon 1, and intron 1), and 33 kb of the upstream sequence Kuzmin et al., 1994) . G418 resistant clones were expanded and analysed by Southern hybridization using double digestion with EcoRI and NotI. The EcoRI digest discriminates between the endogenous 20 kb and the transgenic 7 kb VHL fragments. When the VHL CpG island is unmethy- lated, an EcoRI/NotI double digest would produce 0.8 and 6 kb EcoRI/NotI fragments instead of the 7 kb EcoRI fragment. In all cosmid 11 transfectants, double digest yielded 0.8 and 6 kb fragments, indicating that at least the majority of the transgenic VHL CpG islands were free of methylation. To further analyse methylation of the 5'¯anking genomic sequences of the transgene, DNA from a stable clone LC11-17, which was maintained for 20 passages, was treated with bisul®te, ampli®ed by PCR, subcloned and sequenced. A single polymorphic nucleotide in position 7128 made the origin of a particular copy traceable to cosmid 11. Among several endogenous copies, one copy (plasmid clone) of the cosmid 11 VHL allele was isolated after conversion and PCR. Sequencing showed that the 5'¯anking Alu repeat element remained mostly unmethylated: 18 out of 20 CpGs were unmethylated in the region spanning nucleotides 7210 through 7585; the only two methylated CpGs were found in positions 7353 and 7271. Therefore, in contrast to endogenous sequences, stably integrated transgenic VHL 5'¯anking genomic regions, including repetitive elements, remained hypomethylated after 20 passages in cell culture. Collectively, the transfection experiments with VHL promoter driven minigenes and the VHL containing cosmid demonstrate that the UOK 121 cells, with a heavily methylated VHL endogene, keep transfected VHL alleles free of methylation.
Single chromosome 3 transfer into UOK 121 cells
To further prove that UOK 121 cells can protect and propagate, free of methylation, VHL alleles introduced in their native chromatin context, we transferred a single chromosome 3 carrying an active wild type VHL allele into UOK 121 cells. Two positive clones (MCH 720.2 and MCH 720.5) were obtained and analysed using a WCP 3 painting probe (Oncor). This probe revealed one additional chromosome 3 in the hybrids compared to parental UOK 121 cells, which contained two normal looking 3's and two 3q11 translocations (Figure 3 ). Southern blot hybridization (double XbaI/ NotI digestion) and RT ± PCR analysis of transcription were used to ascertain methylation and expression of the introduced VHL gene. As evidenced by the presence of the 1 kb NotI/XbaI fragment on Southern blots and RT ± PCR analysis, the newly introduced was used as a probe. DNA from each stably transfected clone was digested with EcoRI/NotI. The presence of 0.9 and 6.2 kb EcoRI/NotI fragments indicates that the cosmid 11 VHL NotI site is methylation free. Endogenous VHL EcoRI fragment is, as expected, 20 kb long Figure 3 FISH analysis of the parental UOK 121 cells and the UOK 121 ± chromosome 3 microcell hybrid MCH 720.5. The copies of chromosome 3 are visualized by in situ hybridization using a chromosome 3-speci®c library probe. The two normal copies of chromosome 3 in UOK 121 and three normal copies of chromosome 3 (including the transferred chromosome 3) in MCH 720.5 are identi®ed by an arrowhead VHL allele remained unmethylated and transcriptionally active in the UOK 121 cells (Figure 4) . To exclude the possibility of mutations in the transferred active VHL allele, we isolated and sequenced its coding regions by RT ± PCR. No mutations were found. The eect of the transferred chromosome 3 on growth and tumorigenicity of the modi®ed UOK 121 RCC cells will be reported elsewhere (Stanbridge et al., in preparation).
Methylation status of the VHL gene in somatic cell hybrids
We reasoned that somatic cell fusion may shed more light on the defect in the UOK 121 cells containing abnormally methylated VHL locus. In particular, we wished to investigate if other chromosomes and transfactors factors could change the VHL methylation status, or bring about demethylation of the heavily methylated UOK 121 VHL allele. To analyse these possibilities we created somatic cell hybrids between the UOK 121 and UMRC 6 cells. The methylated or unmethylated mutated VHL endogenes in these partners were haplotyped using four RFLP/SNPs located within the VHL gene: an A/G SNP at position 7128 Geil et al., 1998) , TaqI and PstI RFLPs inside the VHL intron 2 (Richards et al., 1993) and a 1149 A/G SNP in the 3' UTR of the VHL mRNA (Payne et al., 1994) . For the UMRC 6/UOK 121 pair, all RFLPs/SNPs were found to be informative. Cytogenetic analysis indicated the presence of 4 ± 5 copies of chromosome 3 in both cell lines, UMRC 6 and UOK 121 (data not shown), however, each of the cell lines contained only one VHL allele. For selection of the UMRC 6/UOK 121 hybrids dierent selective markers were introduced into the parental cell lines. The UMRC 6 cells were transfected with plasmid p3'SS (Stratagene), conferring hygromycin resistance. A G418 resistant clone L24, containing one copy of the VHL minigene and obtained after transfection of the UOK 121 cells with pRcpVHLm, was used as a second parent. Using the 7128 and +1149 SNPs, we demonstrated that in three fusion hybrid clones (L&U4, L&U5 and L&U6) both parental VHL alleles were present (Figure 5a ). On average, the hybrid clones contained 100 ± 110 chromosomes as compared to 60 ± 70 in each of the parental cell lines (data not shown). Southern blot hybridization (double XbaI/NotI digestion) showed that hybrids L&U4, L&U5 and L&U6 contained both methylated and unmethylated NotI sites (Figure 5b ). Methylation status of the VHL CpG island in the hybrids was further analysed using the bisul®te sequencing protocol. UMRC 6 and UOK 121 alleles were distinguished by the 7128 SNP. In all sequenced copies of the UMRC 6 allele, the VHL CpG island was shown to be free of methylation, while the UOK 121 allele was always heavily methylated (close to 100%). In agreement with these results, the endogenous 4.8 kb VHL mRNA was expressed in the hybrids (Figure 4c) . Using RT ± PCR analysis of the RNA, which includes the +1149 SNP, we proved that this transcript originated exclusively from the UMRC 6 VHL allele (data not shown). These results clearly demonstrate that the UOK 121 VHL allele was not re-expressed in somatic cell hybrids and remained methylated. In contrast, the VHL allele contributed by the UMRC 6 cells remained methylation free and transcriptionally active.
Methylation patterns of sequences¯anking the VHL gene
A large number of studies showed a correlation between methylation status of a CpG rich promoter and the neighboring CpG islands in certain imprinted genes (Ainscough et al., 1997; Wutz et al., 1997) . We next determined whether methylation of the VHL CpG island correlated with methylation (demethylation) of its neighboring CpG clusters. According to the restriction map of the VHL locus Kuzmin et al., 1994) , the nearest CpG rich regions were located 35 kb upstream and 23 kb downstream of the VHL promoter. Both of them contain NotI sites. We subcloned sequences around these NotI sites and used them as probes for Southern blot hybridization of EcoRI/NotI digested DNA from UOK 121, RXF 393 (Stinson et al., 1992) , UMRC 6 and 786 ± 0 (Williams et al., 1976 ) RCC cell lines (Figure 6 ). In all four samples the downstream NotI site was unmethylated while the upstream NotI site was methylated. We also analysed two SmaI sites, one located within the VHL 3' UTR and the other one within intron 2 (positions 7287 and 12211 respectively, GenBank accession #AF010238). These sites were methylated in all four cell lines (Figure 6 ). Therefore, using Southern blot hybridization for long range methylation analysis, we found no correlation between the methylation status of the VHL CpG island and regions¯anking the VHL locus. We did not ®nd any gross genomic rearrangements within the VHL locus of the UOK 121 and RFX 393 cells. Only normal size EcoRI and XbaI fragments were revealed by Southern blot hybridization. This result argues against the possibility that in the UOK 121 and RFX 393 cells the VHL locus might have somehow assumed a more`repressive' chromatin con®guration or that a methylation center exerting a silencing eect was inserted nearby.
To determine the local VHL methylation pattern in greater detail, the VHL CpG island and adjacent Alu repeats were subjected to bisul®te sequencing ( Figure  6 ). The repeat located inside intron 1 and immediately downstream from the VHL CpG island (positions 1210 through 1520, GenBank accession #AF010238) was only partially methylated in the UMRC 6 cells but fully methylated in UOK 121. The Alu repeat upstream of the VHL promoter (positions 7585, 7220; accession number U19763) was fully methylated in both cell lines. It is noteworthy, that dierent copies of the partially methylated downstream Alu repeat have dierent methylated CpGs, indicating, that in this region particular CpG dinucleotides undergo frequent methylation/demethylation.
Discussion
Abnormal methylation of tumor suppressor genes is a consistent feature of neoplastic cells. The VHL gene is hypermethylated and silenced in about 20% of the clear cell type RCCs. The factors which cause and To evaluate these factors we transferred unmethylated VHL alleles into the clear cell RCC cell line UOK 121, which contains a hemizygous methylated VHL endogene.
First we employed a transfection strategy to introduce a VHL minigene and a VHL-containing cosmid into the UOK 121 cells. As demonstrated by Southern and Northern blot analysis and bisul®te sequencing in both types of transgenes, the VHL CpG island remained unmethylated and transcription from the minigene was comparable to that in VHL expressing clear cell RCC lines. These results implied that the VHL-speci®c promoter-interacting trans factors are abundant in UOK 121 cells and therefore are not causative for VHL methylation in these cells. In addition bisul®te sequencing analysis indicated that the¯anking genomic regions remained largely unmethylated in both transgenes in contrast to the endogenous VHL alleles.
Next, to test the possibility of de novo methylation of the VHL gene, which is introduced in its proper chromatin context and includes properly methylated CpG¯anking sequences, we transferred a single human chromosome 3 from mouse parental cells into the UOK 121 cells. Using Southern blot hybridization and RT ± PCR, we con®rmed the presence of an unmethylated and transcribed VHL allele in the cell clones with an additional chromosome 3. The introduced VHL allele was free of mutations. Thus, even in its native chromatin environment, the VHL gene remained unmethylated, further strengthening the argument that trans-acting factors (or their de®cit) are not responsible for maintaining VHL methylation in UOK 121 cells.
Finally, UOK 121 cells were used to create a set of somatic cell hybrids. The UMRC 6 clear cell type RCC line, containing a mutated hypomethylated transcribed VHL allele, was chosen as a second parent. The hybrid clones were analysed using Southern and Northern blot hybridization, RT ± PCR and bisul®te sequencing. A number of SNP and RFLP dierences between UMRC 6 and UOK 121 VHL alleles allowed analysis of methylation and transcriptional status of each allele type separately. The results concurred with those obtained previously for chromosome 3 transfer and gene transfection experiments, i.e. all the UMRC 6 copies of the VHL gene remained active and hypomethylated, while the UOK 121 copies remained hypermethylated and silenced.
Taken together our ®ndings demonstrate, that in UOK 121 de novo methylation of the introduced VHL gene or demethylation of the VHL endogene cannot be induced in trans. Therefore, the abnormal methylation of the endogenous VHL allele in these cells is dependent upon some cis-speci®c feature(s). Several possibilities concerning the nature of the de novo and maintenance methylation mechanisms remain open: (1) UOK 121 cells may contain a mutation in an as yet unidenti®ed methylation controlling cis element, causing methylation of the VHL CpG island. We found no mutations in UOK 121 cells within the GC- (data not shown) . Thus, such an element, if it exists, must be located outside of the VHL promoter and CpG island. In this case, the nature of the methylation defect in UOK 121 cells would be similar to that in the familial imprinting-de®cient forms of the Prader-Willi and Angelman syndromes (Reis et al., 1994; Sutclie et al., 1994; Buiting et al., 1995) . Here the imprinting defects are caused by mutations (deletions) within a small distal area (imprinting center) positioned in cis from the aected genes. This scenario would predict the existence of a hereditarỳ VHL-hypermethylated' form carrying a mutant cis element in one copy of the VHL gene as a ®rst hit. However, germline mutations aecting either the splicing or VHL protein coding sequence have already been identi®ed in 93 (all samples studied) VHL families (Stolle et al., 1998) . This would allow only a very low frequency of hereditary`methylation causing mutations' implying that such hypothetical germline mutations may not be tolerated in development. Lastly, these mutations could be located very far from the corresponding promoter and may be dicult to pinpoint. (2) The aberrant VHL hypermethylation in UOK 121 cells may not be caused by mutation at all and therefore represent a`spontaneous'`epigenetic' type cis-defect. This defect could be similar in nature to the imprinting defect in a small subset of sporadic cases of Prader-Willi and Angelman syndromes that was never observed in hereditary forms (BuÈ rger et al., 1997; Buiting et al., 1998) . In these cases the imprinting center is not mutated and some of the patients share the paternal (Prader-Willi) or the maternal (Angelman syndrome) haplotype with an unaected sib.
Our data demonstrate that additional trans factors are not required for protection of the introduced VHL alleles in UOK 121 cells. However, the initial de novo methylation of the UOK 121 VHL allele could have been caused by a temporary abnormal expression or absence of some hypothetical trans-acting factor(s). Such an event cannot be excluded or proved within the scope of the available experimental data. With more established RCC lines available in the future, it might become possible to ®nd lines retaining both mutated and methylated VHL alleles, thereby excluding transacting factors as a causative for VHL de novo methylation in such cell lines. Long range sequencing of the methylated VHL loci in clear cell RCC samples with distinct histories of VHL methylation may help to de®ne the nature of the cis elements responsible for the aberrant VHL methylation.
Materials and methods
Constructs and probes
Plasmid pRCpVHLm containing the VHL minigene was described elsewhere (Kuzmin et al., 1995) . Brie¯y the CMV enhancer/promoter of the pRC/CMV expression vector (Invitrogen) was substituted by the VHL cDNA fused with a 5'¯anking genomic region (VHL minigene, nt 7647 +710, plasmid pRCpVHL). pRCpVHL was digested with BstEII, ®lled-in and religated creating a frameshift in the VHL ORF.
Cosmid 11 was previously described . It contains 37 kb of genomic DNA including the VHL promoter, exon 1, intron 1 and 31 kb of upstream genomic sequence.
The downstream GC-rich region was subcloned from cosmid 3 , as a 0.5 kb EcoRI/SalI fragment and used as a probe. The upstream GC-rich fragment was subcloned from the lambda phage X36 (Kuzmin et al., 1994) as a 2.2 kb Tth 111 I fragment, and partially sequenced. A unique sequence probe (900 bp) was ampli®ed with primers CTG CAC CTC TTC GCA CAA AG and AAC CTG ACA GAG CTC TGG GT and used for Southern blot hybridization. Whole group 7 VHL cDNA was used for Northern blot hybridization. For the XbaI/SmaI Southern blots, we used, as a probe, the VHL ORF or a 3' UTR fragment obtained by cutting the group 7 cDNA with XbaI/EcoRI.
Generation of L&U somatic cell hybrids UMRC 6 (Grossman et al., 1985) renal carcinoma cells were transfected with the plasmid p3'SS using lipofection (Life Technologies, Inc.) and selected for hygromycin resistance. UOK 121 cells (Herman et al., 1994) were similarly transfected with the plasmid pCRpVHLm and selected for G418 resistance. One clone which had a single nonrearranged copy of the VHL transgene (clone L24) was used for fusion. The presence of both VHL alleles was con®rmed using four informative RFLPs/SNPs (restriction fragment length polymorphisms/single nucleotide polymorphisms) within the VHL gene.
Chromosome 3 transfer into UOK 121 cells
Microcells were prepared from the mouse A 9 microcell hybrid MCH903.1, which contain a normal human chromosome 3 with a neo selective marker (Cheng et al., 1998) and fused with the UOK 121 cells. Stable clones were selected using 600 mg/ml G418. Two G418 resistant clones were analysed by Southern blot hybridization and RT ± PCR. Primers used for RT ± PCR were: VHLIg2F: GTC ACC TTT GGC TCT TCA GA and VHL6b2R: GCT GAG ATG AAA CAG TGT AAG. 25 PCR cycles (948C 30 s, 608C 30 s, 728C 1 min) were followed by a 10 min extension at 728C (9600 Perkin Elmer PCR unit). PCR products were analysed using gradient 4 ± 20% polyacrylamide gels (Novex).
Fluorescent in situ hybridization (FISH)
Metaphase spreads were prepared according to standard cytogenetic procedures. The chromosome 3 content of the parental cell line UOK 121 and the hybrid MCH 720.5 were determined by using a chromosome 3-speci®c library probe (Oncor). The probe was labeled with dioxigenin and the hybridization was detected with Rhodamine anti-deoxigenin Fab fragments (Boehringer). Slides were counterstained with 4,6-diamidino-2-phenylindole (DAPI) and the¯uorescent signals were viewed with a Zeiss axioscop epi¯uorescence microscope with a triple band ®lter (Chroma Tech 61002). The images were captured and digitally enhanced using the Oncor Imaging System and Adobe Photoshop.
Bisul®te treatment and sequencing of DNA Cells were lysed in 1% sodium dodecyl sulfate/0.5 mg/ml proteinase K (Boehringer Mannheim GmbH) and incubated 4 h at 458C. DNA was sheared using 27G1/2 needles, extracted with phenol/chloroform and precipitated. 20 mg of DNA were denatured in 600 ml 0.4 N NaOH at 378C for 10 min, added to 50 ml of 5 M sodium bisul®te/ 100 mM hydroquinone pH 5.0 and incubated 4 h at 508C. DNA was concentrated using Centricon 50 concentrators (Amicon) precipitated with ethanol redissolved in TE and used for nested PCR. In all cases, a sense strand of bisul®te-converted DNA was analysed.
For ampli®cation of the VHL minigene promoter (NT 7647 7122) vector-speci®c primers were used: BIS/CMV-1: AGA ATT TGT TTA GGG TTA GG and BIS5R: ATA ACC RAC CRA AAA CTA TAC for ®rst PCR and BIS/ CMV-2 GGT TTG ATY GAT AAT TGT ATG A together with BIS4R: CAA AAA AAT CCT CCA ACA CC for nested PCR. To analyse methylation of the VHL endogenes (NT 7690 7122) in L&U hybrids we used primers BIS7D: GAG TGT TTA TGT TTG TAG TTT TA and BIS8D: GAG TGT TTT GTA TAT AGT AGG for ®rst and nested PCR together with BIS5R and BIS4R. The VHL CpG island (NT 7154 intron 1 NT66) was ampli®ed using forward primers BIS1D: TAT TAA ATT TTA GAG GGG TG and BIS21D: AGT GGA AAT ATA GTA AYG AG together with reverse primers BIS2R: CTC AAA AAA CCT CAA TTC CCC and BIS3R: TCT ACA AAA TAA ACC CCR AA, where the BIS1D/BIS2R primer pair was designated for ®rst PCR and BIS21D/BIS3R for nested PCR. For VHL intron 1 sequences (NT 87 ± 502) we used forward primers BIS11D: GAT TTA GTA GGG AYG ATA GTA (®rst PCR), BIS12D: GTT TYG GGG TTT ATT TTG TAG A (nested PCR) and reverse primers BIS11R: CTC CAC RAA AAC AAA AAC TAC (®rst PCR), BIS12R: CAA AAC TAA CCC ACT AAA ATC (nested PCR). For primers pairs BIS1D/BIS2R and BIS21D/BIS3R, PCR conditions in a 9600 Perkin Elmer PCR unit were: 948C 30 s, 508C 30 s, 728C 2 min; 35 cycles. For the other primers the annealing temperature was increased to 588C. PCR products were subcloned using a TA cloning kit (Invitrogen) and sequenced on a 373 DNA Sequencer (Applied Biosystems).
